In Silico Design of Novel Anticoagulant Peptides targeting Blood Coagulation Factor VIIa

Journal Title: Sultan Qaboos University Medical Journal - Year 2011, Vol 11, Issue 1

Abstract

Objectives: Te coagulation cascade initiated during vascular injury prevents bleeding. Unwanted clot formation is however detrimental and requires the use of anticoagulants for prophylaxis and treatment. Anticoagulants targeting a specifc step or an enzyme in the clotting process are most preferred as they minimise disadvantageous side-effects. A principal step in the discovery of novel anticoagulants encompasses the in silico design of potential leads. Tis study depicts the in silico design of peptide anticoagulants targeting coagulation factor VIIa. Methods: Applying the proline bracket rule and using various bioinformatics tools: the basic alignment search tool (BLAST) of National Center for Biotechnology Information; the T-coffee module provided by European Molecular Biology Laboratory-European Bioinformatics Institute, and several modules available on the ExPASy server, we designed fve bivalent chimeric anticoagulants targeting factor VIIa, using factor VIIa inhibitors – hemextin A from Hemachatus haemachatus (African Ringhals cobra) venom and factor VIIa exosite-inhibitor peptide as templates. Six peptides were derived from hemextin A, which were concomitantly fused with factor VIIa exosite-inhibitor peptide intermediated by a polyalanine spacer, and analysed for structural stability using the SWISS-MODEL software developed at the Swiss Institute of Bioinformatics and WebLab ViewerPro (Version 4.2). Results: Twelve chimeric peptides were obtained; only fve exhibited stable structures in silico. Conclusion: Te fve peptides obtained are probable anticoagulant leads that should be further evaluated using suitable in vitro and in vivo assays. Further, this study shows how simple web-based modules can be used for the rational design of probable leads targeting specifc physiological molecular targets.

Authors and Affiliations

Manal S Q Al-Amri| Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman, Khalid Alrasadi| Department of Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman, Riad Bayoumi| Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman, Yajnavalka Banerjee| Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Keywords

Related Articles

Oral Manifestations and Complications of Diabetes Mellitus A review

Diabetes mellitus is a chronic disease affecting all age groups. It is one of the leading causes of mortality and morbidity worldwide. Many chronic macrovascular and microvascular complications of diabetes have been r...

Urinary Bladder Stone Complicating Ventriculovesical Shunt

Te standard treatment for hydrocephalus is either a ventriculoperitoneal or a ventriculo-atrial shunt. However, these conventional shunts may be associated with considerable complications and high revision rates which...

The Medical Case for a Positron Emission Tomography and X-ray Computed Tomography Combined Service in Oman

Te value of a positron emission tomography and X-ray computed tomography (PET/CT) combined service in terms of diagnostic accuracy, cost-effectiveness and impact on clinical decision-making is welldocumented in the...

Cephalometric Norms in an Omani Adult Population of Arab Descent

Objectives: Tis study aimed to establish cephalometric norms for an Omani population of Arab descent and to compare these with established cephalometric values for Caucasians. Methods: Tis cross-sectional study was con...

Download PDF file
  • EP ID EP14023
  • DOI -
  • Views 276
  • Downloads 10

How To Cite

Manal S Q Al-Amri, Khalid Alrasadi, Riad Bayoumi, Yajnavalka Banerjee (2011). In Silico Design of Novel Anticoagulant Peptides targeting Blood Coagulation Factor VIIa. Sultan Qaboos University Medical Journal, 11(1), 83-94. https://europub.co.uk/articles/-A-14023